Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

IHG announces $900m share buyback after year of growth

(Sharecast News) - InterContinental Hotels Group (IHG) reported a full year of growth on Tuesday, alongside a fresh $900m share buyback programme and the acquisition of the Ruby lifestyle hotel brand. The FTSE 100 hotel giant, which operates a multitude of brands including Crowne Plaza and Holiday Inn, said revenue from reportable segments in 2024 rose 7% to $2.31bn, while operating profit increased 10% to $1.12bn.

Adjusted earnings per share climbed 15% to 432.4 cents.

The fee business revenue grew 6% to $1.77bn, and the company's fee margin improved by 1.9 percentage points to 61.2%.

However, IFRS operating profit declined 2% to $1.04bn due to a loss in the System Fund, and basic earnings per share fell 12% to 389.6 cents.

The total dividend per share for the year rose 10% to 167.7 cents.

IHG said it saw continued growth in its hotel network, adding 59,100 rooms across 371 hotels, a 23% year-over-year increase.

The company signed 106,200 rooms, a 34% rise from 2023, driven by an 88% increase in hotel conversions.

Its total global pipeline now stood at 325,000 rooms across 2,210 hotels, up 10% year-on-year.

IHG's revenue per available room (RevPAR) grew 3%, with strong performance in EMEAA of 6.6% growth, and the Americas, up 2.5%, offsetting a 4.8% decline in Greater China.

IHG chief executive officer Elie Maalouf said 2024 was an "excellent year" of financial performance, growth and progress.

"We continue to strengthen our enterprise to position IHG as the first choice for guests and owners, further improving and growing our brands, driving loyalty contribution, rolling out new hotel technology and increasing our ancillary fee streams," he said.

"Our cash generation and strong balance sheet supports further investment in growth, and we also continue to sustainably increase our ordinary dividend and the regular return of surplus capital through share buybacks.

"We enter 2025 with confidence in further capitalising on our scale, leading positions and the attractive longterm demand drivers for our markets, all of which supports the ongoing successful delivery of our growth algorithm."

In line with its commitment to returning capital to shareholders, IHG completed an $800m share buyback in 2024, and announced a new $900m repurchase programme for 2025.

The board said the new buyback, to be conducted through Merrill Lynch International, was designed to reduce the company's outstanding share count.

IHG also announced the expansion of its brand portfolio with the acquisition of Ruby, marking its 20th brand.

The initial purchase cost of $116m would provide IHG with a premium urban lifestyle brand known for its "lean luxury" concept, featuring space-efficient designs and high levels of automation.

Ruby currently operates 20 hotels across major European cities, with 10 more in development.

IHG said it planned to expand the brand globally, targeting over 120 properties within the next decade and more than 250 over 20 years.

The company said it was aiming to introduce Ruby in the US market by the end of the year.

"This acquisition demonstrates our focus on building our presence in large, attractive industry segments and using our experience of integrating and growing brands and hotel portfolios," IHG CEO Elie Maalouf added.

"The urban micro space is a franchise-friendly model with attractive owner economics, and we see excellent opportunities to not only expand Ruby's strong European base but also rapidly take this exciting brand to the Americas and across Asia, as we have successfully done with previous brand acquisitions."

At 0825 GMT, shares in InterContinental Hotels Group were down 1.64% at 10,520p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.